Atypical BMI Trajectory Detectable in Children as Early as Age 3.5 Years
THURSDAY, June 5, 2025 -- Children on the path to obesity can be detected as early as age 3.5 years, according to a study published online May 22 in JAMA Network Open.
Chang Liu, Ph.D., from Washington State University in Pullman, and colleagues examined how early-life factors are associated with body mass index (BMI) trajectories in children. The analysis included participants in the Environmental influences on Child Health Outcomes cohort, which included children aged 1 to 9 years (January 1997 to June 2024).
The researchers identified two distinct two-phase BMI patterns. The typical group (89.4 percent) showed linear decreases in BMI, with the lowest BMI at age 6 years, followed by linear increases from 6 to 9 years (mean BMI at 9 years: 17.33 kg/m2). The atypical group (10.6 percent) showed a stable BMI from ages 1 to 3.5 years, followed by rapid linear increases from ages 3.5 to 9 years and a mean BMI at age 9 years of 26.2 kg/m2, which exceeded the 99th percentile. Risk factors associated with the atypical trajectory included prenatal smoking, high prepregnancy BMI, high gestational weight gain, and high birth weight.
"The fact that we can identify unusual BMI patterns as early as age 3.5 shows how critical early childhood is for preventing obesity," Liu said in a statement. "Our findings suggest there are important opportunities to reduce childhood obesity, such as helping pregnant women quit smoking and manage healthy weight gain, as well as closely monitoring children who show early signs of rapid weight gain."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Read this next
Cancer Survival Lower in Rural Areas
WEDNESDAY, Oct. 1, 2025 -- Five-year cancer survival rates for each stage of cancer (localized, regional, and distant) is lower in nonmetropolitan areas for Black and White...
Metabolic Surgery Has Greater Long-Term Benefits Than GLP-1 Receptor Agonists
WEDNESDAY, Oct. 1, 2025 -- People with obesity and type 2 diabetes who undergo metabolic surgery live longer and face fewer serious health problems compared with patients treated...
Loss of Smell May Linger After COVID-19
WEDNESDAY, Oct. 1, 2025 -- Self-reported change or loss in smell or taste is an accurate signal of verified hyposmia after COVID-19, although there is also a high rate of hyposmia...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.